LobbyingAeroflow Healthcare lobbying by quarter
Aeroflow Healthcare's latest lobbying report covers Q3 2026, at under $5,000. Its first report covers Q2 2023; the issues it reports most are Health Issues and Miscellaneous Tariff Bills.
Aeroflow Healthcare
- Latest quarter
- $0
- Q3 2026 · 1 reports
- Last 12 months
- $0
- Last 4 quarters
- vs last quarter
- No record
- Q3 2026 against the quarter before
- First report
- Q2 2023
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q2 2023 | $0 | 1 |
| Q3 2023 | $0 | 1 |
| Q4 2023 | $0 | 1 |
| Q1 2024 | $0 | 1 |
| Q2 2024 | $0 | 1 |
| Q3 2024 | $0 | 1 |
| Q4 2024 | $0 | 1 |
| Q1 2025 | $10K | 1 |
| Q2 2025 | $10K | 1 |
| Q3 2025 | $0 | 1 |
| Q4 2025 | $0 | 1 |
| Q1 2026 | $0 | 1 |
| Q2 2026 | $0 | 1 |
| Q3 2026 | $0 | 1 |
By issue
- Health issues$10K · 14 reports
- Tariffs$10K · 7 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- Administration on Aging14 reports
- Centers For Medicare and Medicaid Services (CMS)14 reports
- Health & Human Services, Dept of (HHS)14 reports
- HOUSE OF REPRESENTATIVES14 reports
- SENATE14 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseAeroflow Healthcare | $20K | 14 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/21for Q3 | In-house | Under $5,000 |
| 07/21for Q2 | In-house | Under $5,000 |
| 04/29for Q1 | In-house | Under $5,000 |
| 01/22for Q4 2025 | In-house | Under $5,000 |
| 25/11/06for Q3 2025 | In-house | Under $5,000 |
| 25/07/14for Q2 2025 | In-house | $10K |
| 25/04/11for Q1 2025 | In-house | $10K |
| 25/01/10for Q4 2024 | In-house | Under $5,000 |
| 24/10/12for Q3 2024 | In-house | Under $5,000 |
| 24/07/11for Q2 2024 | In-house | Under $5,000 |
| 24/04/12for Q1 2024 | In-house | Under $5,000 |
| 24/01/18for Q4 2023 | In-house | Under $5,000 |
| 23/10/06for Q3 2023 | In-house | Under $5,000 |
| 23/07/18for Q2 2023 | In-house | Under $5,000 |
| 23/04/12for Q2 2023 | In-house | Under $5,000 |